Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 DKK)

NET PROFIT (x1000 DKK)

Share

Novo Nordisk Pharma Operations A/S

Closing information (x1000 DKK)

Closing information 2023/12 2022/12 2021/12
Turnover 108,302 More Arrow 211,440 Less Arrow 98,630
Earnings before taxes 6,765 Less Arrow 4,779 Less Arrow 4,398
Total assets 77,875 More Arrow 135,750 Less Arrow 70,860
Current assets 69,808 Less Arrow 55,676 More Arrow 59,841
Current liabilities 35,410 Less Arrow 34,957 More Arrow 42,493
Equity capital 28,925 More Arrow 71,709 Less Arrow 20,538
- share capital 500 Equal arrow 500 Equal arrow 500
Employees (average) 0 Equal arrow 0 Equal arrow 0

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 37.1% More Arrow 52.8% Less Arrow 29.0%
Turnover per employee
Profit as a percentage of turnover 6.2% Less Arrow 2.3% More Arrow 4.5%
Return on assets (ROA)
Current ratio 197.1% Less Arrow 159.3% Less Arrow 140.8%
Return on equity (ROE) 23.4% Less Arrow 6.7% More Arrow 21.4%
Change turnover -103,138 More Arrow 112,810 Less Arrow 19,433
Change turnover % -49% More Arrow 114% Less Arrow 25%
Chg. No. of employees 0 Equal arrow 0 Equal arrow 0
Chg. No. of employees %

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.